Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
It is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. Antidepressant.